GLIS2 and acute myeloid leukemia: Notably, in the present work, we demonstrate that patients harboring the DHH-RHEBL1 fusion present an overexpression of DHH compared to both CBFA2T3-GLIS2-positive patients and CN-AML patients (Figure 2A).